Back to News
Feb 6, 2026 8:01 AM

Immunovant Q3 Earnings Assessment

Immunovant (NASDAQ:IMVT) announced its Q3 earnings on Friday, February 6, 2026 at 07:00 AM.

Here's a breakdown of the earnings report.

Earnings

Immunovant beat estimated earnings by 14.08%, reporting an EPS of $-0.61 versus an estimate of $-0.71.

Revenue was down $0 from the same period last year.

Previous Earnings Records

Last quarter the company missed ...